Filing Details
- Accession Number:
- 0001127602-10-017925
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-29 13:00:00
- Reporting Period:
- 2010-06-25
- Filing Date:
- 2010-06-29
- Accepted Time:
- 2010-06-29 10:05:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874663 | Alkermes Inc | ALKS | Pharmaceutical Preparations (2834) | 232472830 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376548 | Elliot Ehrich | 852 Winter St. Waltham MA 02451 | Svp, R&D & Chief Medical Ofcr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-06-25 | 15,245 | $7.36 | 52,324 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-06-25 | 15,245 | $13.00 | 37,079 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualified Stock Option (Right to Buy) | Disposition | 2010-06-25 | 15,245 | $0.00 | 15,245 | $7.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-12-12 | 2012-12-12 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing one year after the grant date.
Billionaire Hedge Funds
